D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 7.54 USD -0.66%
Market Cap: 69.7m USD

Wall Street
Price Targets

CRVO Price Targets Summary
Diffusion Pharmaceuticals Inc

Wall Street analysts forecast CRVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRVO is 22.88 USD with a low forecast of 15.15 USD and a high forecast of 32.55 USD.

Lowest
Price Target
15.15 USD
101% Upside
Average
Price Target
22.88 USD
203% Upside
Highest
Price Target
32.55 USD
332% Upside
Diffusion Pharmaceuticals Inc Competitors:
Price Targets
SBTX
SkinBioTherapeutics PLC
58% Upside
MSB
Mesoblast Ltd
35% Upside
NTLA
Intellia Therapeutics Inc
51% Upside
BMEA
Biomea Fusion Inc
370% Upside
CRSP
CRISPR Therapeutics AG
29% Upside
CRNX
Crinetics Pharmaceuticals Inc
58% Upside
XNCR
Xencor Inc
111% Upside
AMRN
Amarin Corporation PLC
19% Downside

Revenue
Forecast

Revenue Estimate
Diffusion Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Diffusion Pharmaceuticals Inc's revenue is 24%. The projected CAGR for the next 4 years is -35%.

24%
Past Growth
-35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Diffusion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Diffusion Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRVO's stock price target?
Price Target
22.88 USD

According to Wall Street analysts, the average 1-year price target for CRVO is 22.88 USD with a low forecast of 15.15 USD and a high forecast of 32.55 USD.

What is Diffusion Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-35%

For the last 13 years the compound annual growth rate for Diffusion Pharmaceuticals Inc's revenue is 24%. The projected CAGR for the next 4 years is -35%.

Back to Top